Results 111 to 120 of about 49,657 (223)

Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis. [PDF]

open access: yesInt J Mol Sci, 2022
Ly TTG   +13 more
europepmc   +1 more source

Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data

open access: yesHIV/AIDS: Research and Palliative Care, 2020
Alexander E Rock,1 Jeremy Lerner,2 Melissa E Badowski1 1University of Illinois, College of Pharmacy, Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, Chicago, IL 60612, USA; 2University of Illinois, College of Pharmacy ...
Rock AE, Lerner J, Badowski ME
doaj  

Factors Associated with the Emergence of K65R in Patients with HIV-1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir [PDF]

open access: yes, 2017
Background. The human immunodeficiency virus type 1 reverse-transcriptase mutation K65R is a single-point mutation that has become more frequent after increased use of tenofovir disoproxil fumarate (TDF). We aimed to identify predictors for the emergence
Battegay, Manuel   +13 more
core  

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection [PDF]

open access: yes, 2003
Although the pathogenesis of human immunodeficiency virus (HIV) infection and the general virologic and immunologic principles underlying the use of antiretroviral therapy are similar for all HIV-infected persons, there are unique considerations needed ...
Antiretroviral Therapy and Medical Management of HIV-Infected Children, ATMMHC   +3 more
core  

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy. [PDF]

open access: yesElife, 2021
Pasternak AO   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy